Tamoxifen dosing for Cre-mediated recombination in experimental 
bronchopulmonary dysplasia

Ruiz-Camp, Jordi; Rodriguez-Castillo, Jose Alberto; Herold, Susanne; Mayer, Konstantin; Vadasz, Istvan; Tallquist, Michelle D.; Seeger, Werner; Ahlbrecht, Katrin; Morty, Rory E.

doi:10.1007/s11248-016-9987-8

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Tamoxifen dosing for Cre-mediated recombination in experimental bronchopulmonary dysplasia

MPS-Authors

/persons/resource/persons224328

Ruiz-Camp, Jordi
Lung Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons228726

Rodriguez-Castillo, Jose Alberto
Lung Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons224334

Seeger, Werner
Lung Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons224295

Ahlbrecht, Katrin
Lung Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons224311

Morty, Rory E.
Lung Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Ruiz-Camp, J., Rodriguez-Castillo, J. A., Herold, S., Mayer, K., Vadasz, I., Tallquist, M. D., et al. (2017). Tamoxifen dosing for Cre-mediated recombination in experimental bronchopulmonary dysplasia. TRANSGENIC RESEARCH, 26(1), 165-170. doi:10.1007/s11248-016-9987-8.

Cite as: https://hdl.handle.net/21.11116/0000-0004-518D-2

Abstract

There is no abstract available